VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/13/15 -- Emerge Resources Corp. ("Emerge") (TSX VENTURE: EME) and Israeli cancer biotechnology company Vaxil Bio Ltd. ("Vaxil") are pleased to announce the completion of approximately $2.7-million by way of subscription receipt ...
↧